CME CME Group Inc - Class A

  1. Stocks
  2. Financial Services
  3. NASDAQ: CME

Price (delayed)

$317.97

Market cap

$113.81B

P/E Ratio

25.87

Dividend/share

$11.3

EPS

$12.29

Enterprise value

$270.22B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 91

As the world's leading derivatives marketplace, CME Group ( www.cmegroup.com ) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants ...

Highlights
The EPS is up by 19% year-on-year and by 3.5% since the previous quarter
The company's net income rose by 17% YoY and by 3% QoQ
CME's P/E is 16% above its last 4 quarters average of 22.3 and 5% above its 5-year quarterly average of 24.6
The equity has declined by 6% year-on-year
Sector: Financial Services
Industry: Financial Data & Stock Exchanges
Website: http://www.cmegroup.com
Peers: MSCI ICE CBOE NDAQ

Key stats

What are the main financial stats of CME

CME stock price

How has the CME Group stock price performed over time
Intraday
0.78%
1 week
3.95%
1 month
14.37%
1 year
12.14%
YTD
16.44%
QTD
21.37%

Financial performance

How have CME Group's revenue and profit performed over time
Revenue
$6.97B
Gross profit
$6.97B
Operating income
$4.58B
Net income
$4.4B
Gross margin
100%
Net margin
63.1%
The company's net income rose by 17% YoY and by 3% QoQ
The operating income is up by 10% YoY and by 3.8% QoQ
The gross profit has increased by 9% YoY and by 2.9% from the previous quarter
CME's revenue is up by 9% year-on-year and by 2.9% since the previous quarter

Price vs fundamentals

How does CME's price correlate with its fundamentals

Growth

What is CME Group's growth rate over time

Valuation

What is CME Group stock price valuation
CME P/E details
P/E
25.87
P/B
4.3
P/S
16.33
EV/EBIT
45.56
EV/EBITDA
43.13
EV/Sales
38.76
The EPS is up by 19% year-on-year and by 3.5% since the previous quarter
CME's P/E is 16% above its last 4 quarters average of 22.3 and 5% above its 5-year quarterly average of 24.6
CME's price to book (P/B) is 43% higher than its 5-year quarterly average of 3.0 and 23% higher than its last 4 quarters average of 3.5
The equity has declined by 6% year-on-year
The P/S is 17% higher than the last 4 quarters average of 14.0 and 16% higher than the 5-year quarterly average of 14.1
CME's revenue is up by 9% year-on-year and by 2.9% since the previous quarter

Efficiency

How efficient is CME Group business performance
CME Group's return on equity has increased by 18% YoY and by 4.5% QoQ
The return on sales is up by 9% year-on-year
CME Group's return on assets has decreased by 4.3% YoY
The ROIC has grown by 2.9% from the previous quarter but it has contracted by 2.7% YoY

Dividends

What is CME's dividend history
Dividend details
DPS
$11.3
Dividend yield
3.55%
Payout ratio
91.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did CME Group financials performed over time
CME Group's total assets is 16% more than its total liabilities
CME Group's total liabilities has increased by 4.1% YoY
CME Group's total assets has increased by 2.6% YoY
The debt to equity has grown by 10% YoY
The equity has declined by 6% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.